VALOR-CKD Post-Hoc Analysis

Joel Topf, MD, of Nephrology Times spoke with Bhupinder Singh, MD, and Stewart Turner, PhD, at the 2024 National Kidney Foundation Spring Clinical Meetings. Drs. Singh and Turner, both of Renibus Therapeutics, discussed post-hoc analysis findings from the VALOR-CKD trial regarding serum bicarbonate concentrations in patients with chronic kidney disease and metabolic acidosis.